Daniel van Den Bergh

Daniel van den Bergh is a seasoned investment professional with extensive experience in the healthcare technology sector. Currently serving as Senior Investment Director at Kaiser Permanente Ventures since 2017, Daniel focuses on investing in transformative healthcare technology companies. Previously, Daniel held multiple roles at Endeavour Vision, leading the US Digital Health practice from January 2022 to December 2024. In addition to investment positions at various healthcare companies, including HealthJoy, NOCD, and Nuvolo, Daniel has contributed to significant acquisitions such as Protenus and Talix. Daniel holds an MBA in Health Care Management and Entrepreneurial Management from The Wharton School and a BS in Biological Engineering and Applied Economics from Cornell University.